163 related articles for article (PubMed ID: 35743211)
1. Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF).
Gonnella R; Zarrella R; Santarelli R; Germano CA; Gilardini Montani MS; Cirone M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743211
[TBL] [Abstract][Full Text] [Related]
2. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways.
Granato M; Rizzello C; Gilardini Montani MS; Cuomo L; Vitillo M; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
J Nutr Biochem; 2017 Mar; 41():124-136. PubMed ID: 28092744
[TBL] [Abstract][Full Text] [Related]
3. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death.
Granato M; Gilardini Montani MS; Santarelli R; D'Orazi G; Faggioni A; Cirone M
J Exp Clin Cancer Res; 2017 Nov; 36(1):167. PubMed ID: 29179721
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
[TBL] [Abstract][Full Text] [Related]
6. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells.
Tsai CY; Chen CY; Chiou YH; Shyu HW; Lin KH; Chou MC; Huang MH; Wang YF
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267216
[TBL] [Abstract][Full Text] [Related]
9. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.
Santarelli R; Pompili C; Gilardini Montani MS; Romeo MA; Gonnella R; D'Orazi G; Cirone M
IUBMB Life; 2021 Jul; 73(7):968-977. PubMed ID: 33987937
[TBL] [Abstract][Full Text] [Related]
11. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
12. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
14. Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.
Granato M; Gilardini Montani MS; Romeo MA; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
Cell Signal; 2017 Dec; 40():239-247. PubMed ID: 28964970
[TBL] [Abstract][Full Text] [Related]
15. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.
Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678
[TBL] [Abstract][Full Text] [Related]
16. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
[TBL] [Abstract][Full Text] [Related]
18. Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.
Matsuno T; Kariya R; Yano S; Morino-Koga S; Taura M; Suico MA; Shimauchi Y; Matsuyama S; Okamoto Y; Shuto T; Kai H; Okada S
Int J Oncol; 2012 Apr; 40(4):1071-8. PubMed ID: 22200846
[TBL] [Abstract][Full Text] [Related]
19. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl Fumarate Induces Apoptosis
Maeta T; Sato T; Asano K; Ito S
Anticancer Res; 2022 May; 42(5):2301-2309. PubMed ID: 35489748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
